← back to search

Christian Regenbrecht

University of Tübingen · DE
Area of research
Oncology · Cancer Research
Research interest
Research interests include Biology, Colorectal cancer, Cancer research, Medicine, Cancer stem cell, and Metastasis.
h-index
citations
968
works
22
NIH funding
primary concept
email

Recent publications

MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer
Cancers 2024cited by 9position: middledoi
Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
BMC Cancer 2023cited by 10position: middledoi
Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for EGR2 in tumorigenesis
iScience 2022cited by 27position: middledoi
RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence
iScience 2021cited by 13position: middledoi
Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models
Molecular Cancer 2021cited by 10position: middledoi
RNA-Sequencing of Long-Term Label-Retaining Colon Cancer Stem Cells Identifies Novel Regulators of Quiescence
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: middledoi
Identification of a Nervous System Gene Expression Signature in Colon Cancer Stem Cells Reveals a Role for Neural Crest Regulators <i>EGR2</i> and <i>SOX2</i> in Tumorigenesis
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: middledoi
Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures
PLoS Genetics 2019cited by 81position: lastdoi
Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
International Journal of Cancer 2019cited by 11position: middledoi
Abstract 4525: Modulating chemoresistance: Uncovering the role of mutant SMAD4<sup>R361H</sup>in colorectal cancer using PDO and PDX models
Tumor Biology 2019cited by 0position: lastdoi
From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity
Frontiers in Pharmacology 2018cited by 22position: middledoi
Abstract 4099: Novel patient-derived 3D (PD3D) cell models and matched patient-derived xenografts (PDX) from peritoneal metastasis of colorectal cancer for drug testing and biomarker analysis
Cancer Research 2018cited by 0position: firstdoi
Abstract 5013: Rapid generation of phenomic and functional profiles of patient-derived 3D cell culture models for identification of treatment vulnerabilities of breast cancer: Early results of the EFRE-PoP project
Cancer Research 2018cited by 0position: lastdoi
Successful generation of patient derived xenografts and patient derived 3D cultures as preclinical models for breast cancer.
Journal of Clinical Oncology 2018cited by 0position: middledoi
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
Nature Communications 2017cited by 344position: middledoi
Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells
Cell Reports 2017cited by 135position: middledoi
The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
Oncogenesis 2017cited by 64position: lastdoi
In Vitro Three-Dimensional Cell Cultures as Tool for Precision Medicine
2017cited by 4position: lastdoi
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures
SLAS DISCOVERY 2016cited by 151position: middledoi
Abstract 2412: Reconstructing intratumor heterogeneity: lessons from therapeutic intervention in patient-specific models
Cancer Research 2016cited by 0position: lastdoi
Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes
Scientific Data 2015cited by 61position: middledoi
A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
Frontiers in Physiology 2012cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ulrich Keilholz · German Marine Research Consortium11 papers (2017–2022)Reinhold Schäfer · Charité - Universitätsmedizin Berlin10 papers (2016–2022)Dirk Schumacher · German Cancer Research Center10 papers (2016–2022)Johannes Haybaeck · Innsbruck Medical University8 papers (2016–2022) · 7 papers (2016–2019)Martin Lange · Johannes Gutenberg University Mainz6 papers (2016–2022)Guido Gambara · Charité - Universitätsmedizin Berlin6 papers (2018–2021)Joseph L. Regan · Irish Life (Ireland)6 papers (2017–2024) · 5 papers (2017–2022)Joern Toedling · Charité - Universitätsmedizin Berlin5 papers (2019–2022) · 5 papers (2017–2022)Stephanie Staudte · German Cancer Research Center5 papers (2017–2022)Dominik Mumberg · University of Turku5 papers (2017–2022)Karsten Boehnke · Eli Lilly (United States)5 papers (2016–2019)Maxine Silvestrov · Charité - Universitätsmedizin Berlin4 papers (2016–2019)Jens Hoffmann · University Hospital Heidelberg4 papers (2017–2021) · 4 papers (2021–2022)Balázs Győrffy · Royal Canadian Navy4 papers (2021–2022) · 4 papers (2021–2022)Wolfgang Walther · German Cancer Research Center4 papers (2018–2024)